BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors.
about
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors.
@en
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors.
@nl
type
label
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors.
@en
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors.
@nl
prefLabel
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors.
@en
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors.
@nl
P2093
P2860
P50
P1433
P1476
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors
@en
P2093
Angela Cuoghi
Antonella Gurrado
Antonio Cuneo
Daniela Vallerini
Elisabetta Colaci
Fabio Forghieri
Giovanni Riva
Giuseppe Quartuccio
Ilaria Guido
Ivana Lagreca
P2860
P304
P356
10.1182/BLOOD-2016-07-731091
P407
P50
P577
2016-12-07T00:00:00Z